Association of HDL-related loci with age-related macular degeneration and plasma lutein and zeaxanthin: The Alienor study

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Merle, Bénédicte M J ^a,b   Maubaret, Cécilia ^a,b   Korobelnik, Jean François ^a,b,c   Delyfer, Marie Noëlle ^a,b,c   Rougier, Marie Bénédicte ^c   Lambert, Jean Charles ^a,d,e   Amouyel, Philippe ^a,d,e   Malet, Florence ^c   Le Goff, Mélanie ^a,b   Dartigues, Jean François ^a,b   Barberger Gateau, Pascale ^a,b   Delcourt, Cécile ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

^e UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; XANTHOPHYLL; ZEAXANTHIN;

ABCA1 GENE; AGED; AGING; ARTICLE; CETP GENE; CONTROLLED STUDY; EYE PHOTOGRAPHY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; LIPC GENE; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; LPL GENE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; ONSET AGE; RETINA MACULA AGE RELATED DEGENERATION; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; VITAMIN BLOOD LEVEL;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; GENOTYPE; HUMANS; LIPASE; LIPOPROTEIN LIPASE; LIPOPROTEINS, HDL; LUTEIN; MACULAR DEGENERATION; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; XANTHOPHYLLS;

EID: 84892396509     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079848     Document Type: Article

References (55)

1. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R et al. (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82: 844-851. PubMed: 15640920.
2. Augood CA, Vingerling JR, de Jong PT, Chakravarthy U, Seland J et al. (2006) Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol 124: 529-535. doi:10.1001/archopht.124.4. 529. PubMed: 16606879.
3. Friedman DS, O'Colmain BJ, Muñoz B, Tomany SC, McCarty C et al. (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122: 564-572. doi:10.1001/archopht.122.4.564. PubMed: 15078675.
4. Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY (2012) Age-related macular degeneration. Lancet 379: 1728-1738. doi:10.1016/S0140-6736(12)60282-7. PubMed: 22559899.
5. Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH (2008) Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol 126: 826-833. doi:10.1001/archopht.126.6.826. PubMed: 18541848.
6. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I et al. (2005) Smoking and age-related macular degeneration: a review of association. Eye 19: 935-944. doi:10.1038/sj.eye.6701978. PubMed: 16151432.
7. Chan D (1998) Cigarette smoking and age-related macular degeneration. Optom Vis Sci 75: 476-484. doi:10.1097/00006324-199807000-00015. PubMed: 9703035.
8. van Leeuwen R, Boekhoorn S, Vingerling JR, Witteman JC, Klaver CC et al. (2005) Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 294: 3101-3107. doi:10.1001/jama.294.24.3101. PubMed: 16380590.
9. Kijlstra A, Tian Y, Kelly ER, Berendschot TT (2012) Lutein: more than just a filter for blue light. Prog Retin Eye Res 31: 303-315. doi:10.1016/ j.preteyeres.2012.03.002. PubMed: 22465791.
10. Whitehead AJ, Mares JA, Danis RP (2006) Macular pigment: a review of current knowledge. Arch Ophthalmol 124: 1038-1045. doi:10.1001/archopht.124.7. 1038. PubMed: 16832030.
11. Delcourt C, Carrière I, Delage M, Barberger-Gateau P, Schalch W (2006) Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study. Invest Ophthalmol Vis Sci 47: 2329-2335. doi:10.1167/iovs.05-1235. PubMed: 16723441.
12. (1993) Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-control study group. Arch Ophthalmol 111: 104-109
13. Gale CR, Hall NF, Phillips DI, Martyn CN (2003) Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci 44: 2461-2465. doi:10.1167/iovs.02-0929. PubMed: 12766044.
14. Ma L, Dou HL, Wu YQ, Huang YM, Huang YB et al. (2012) Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis. Br J Nutr 107: 350-359. doi:10.1017/ S0007114511004260. PubMed: 21899805.
15. Clevidence BA, Bieri JG (1993) Association of carotenoids with human plasma lipoproteins. Methods Enzymol 214: 33-46. doi:10.1016/0076-6879(93)14051- J. PubMed: 8469147.
16. Borel P (2012) Genetic variations involved in interindividual variability in carotenoid status. Mol Nutr Food Res 56: 228-240. doi:10.1002/mnfr. 201100322. PubMed: 21957063.
17. Borel P, de Edelenyi FS, Vincent-Baudry S, Malezet-Desmoulin C, Margotat A et al. (2011) Genetic variants in BCMO1 and CD36 are associated with plasma lutein concentrations and macular pigment optical density in humans. Ann Med 43: 47-59. doi:10.3109/07853890.2011.586359. PubMed: 21091228.
18. Borel P, Moussa M, Reboul E, Lyan B, Defoort C et al. (2009) Human fasting plasma concentrations of vitamin E and carotenoids, and their association with genetic variants in apo C-III, cholesteryl ester transfer protein, hepatic lipase, intestinal fatty acid binding protein and microsomal triacylglycerol transfer protein. Br J Nutr 101: 680-687. doi:10.1017/ S0007114508030754. PubMed: 18662427.
19. Chen W, Stambolian D, Edwards AO, Branham KE, Othman M et al. (2010) Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A 107: 7401-7406. doi:10.1073/pnas.0912702107. PubMed: 20385819.
20. Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M et al. (2010) Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A 107: 7395-7400. doi:10.1073/pnas.0912019107. PubMed: 20385826.
21. Yu Y, Reynolds R, Fagerness J, Rosner B, Daly MJ et al. (2011) Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. Invest Ophthalmol Vis Sci 52: 4663-4670. doi:10.1167/iovs.10-7070. PubMed: 21447678.
22. Yu Y, Bhangale TR, Fagerness J, Ripke S, Thorleifsson G et al. (2011) Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet 20: 3699-3709. doi:10.1093/hmg/ddr270. PubMed: 21665990.
23. Sobrin L, Reynolds R, Yu Y, Fagerness J, Leveziel N et al. (2011) ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration. Am J Ophthalmol 151: 345-352 e343 doi:10.1016/j.ajo.2010.08.015. PubMed: 21122828.
24. Peter I, Huggins GS, Ordovas JM, Haan M, Seddon JM (2011) Evaluation of new and established age-related macular degeneration susceptibility genes in the Women's Health Initiative Sight Exam (WHISE) Study. Am J Ophthalmol 152: 1005-1013 e1001 doi:10.1016/j.ajo.2011.05.016. PubMed: 21906714.
25. Seddon JM, Reynolds R, Rosner B (2010) Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration. Mol Vis 16: 2412-2424. PubMed: 21139980.
26. Reynolds R, Rosner B, Seddon JM (2010) Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. Ophthalmology 117: 1989-1995. doi:10.1016/j.ophtha.2010.07.009. PubMed: 20888482.
27. Fauser S, Smailhodzic D, Caramoy A, van de Ven JP, Kirchhof B et al. (2011) Evaluation of serum lipid concentrations and genetic variants at high-density lipoprotein metabolism loci and TIMP3 in age-related macular degeneration. Invest Ophthalmol Vis Sci 52: 5525-5528. doi:10.1167/iovs.10-6827. PubMed: 21613373.
28. Yu Y, Reynolds R, Rosner B, Daly MJ, Seddon JM (2012) Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models. Invest Ophthalmol Vis Sci 53: 1548-1556. doi:10.1167/iovs.11-8657. PubMed: 22247473.
29. Zhang X, Li M, Wen F, Zuo C, Chen H et al. (2013) Different impact of high-density lipoprotein-related genetic variants on polypoidal choroidal vasculopathy and neovascular age-related macular degeneration in a Chinese Han population. Exp Eye Res 108: 16-22. doi:10.1016/j.exer.2012.12.005. PubMed: 23274582.
30. Cipriani V, Leung HT, Plagnol V, Bunce C, Khan JC et al. (2012) Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3. Hum Mol Genet 21: 4138-4150. doi:10.1093/hmg/dds225. PubMed: 22694956.
31. Tian J, Yu W, Qin X, Fang K, Chen Q et al. (2012) Association of genetic polymorphisms and age-related macular degeneration in Chinese population. Invest Ophthalmol Vis Sci 53: 4262-4269. doi:10.1167/iovs.11-8542. PubMed: 22618592.
32. Maller J, George S, Purcell S, Fagerness J, Altshuler D et al. (2006) Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 38: 1055-1059. doi:10.1038/ng1873. PubMed: 16936732.
33. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K et al. (2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41: 56-65. doi:10.1038/ng.291. PubMed: 19060906.
34. van Leeuwen R, Tomany SC, Wang JJ, Klein R, Mitchell P et al. (2004) Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents. Ophthalmology 111: 1169-1175. doi:10.1016/j.ophtha.2003.10.024. PubMed: 15177967.
35. Delcourt C, Michel F, Colvez A, Lacroux A, Delage M et al. (2001) Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthal Epidemiol 8: 237-249. doi:10.1076/opep.8.4.237.1613. PubMed: 11471092.
36. Wachter A, Sun Y, Dasch B, Krause K, Pauleikhoff D et al. (2004) [Munster age- and retina study (MARS). Association between risk factors for arteriosclerosis and age-related macular degeneration]. Ophthalmologe 101: 50-53. doi:10.1007/s00347-003-0868-1. PubMed: 14872268.
37. Nowak M, Swietochowska E, Marek B, Szapska B, Wielkoszynski T et al. (2005) Changes in lipid metabolism in women with age-related macular degeneration. Clin Exp Med 4: 183-187. doi:10.1007/s10238-004-0054-z. PubMed: 15750765.
38. Abalain JH, Carre JL, Leglise D, Robinet A, Legall F et al. (2002) Is age-related macular degeneration associated with serum lipoprotein and lipoparticle levels? Clin Chim Acta 326: 97-104. doi:10.1016/S0009-8981(02) 00288-7. PubMed: 12417100.
39. Tan JS, Mitchell P, Smith W, Wang JJ (2007) Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 114: 1143-1150. doi:10.1016/j.ophtha.2006.09. 033. PubMed: 17275090.
40. Delcourt C, Korobelnik JF, Barberger-Gateau P, Delyfer MN, Rougier MB et al. (2010) Nutrition and age-related eye diseases: the Alienor (Antioxydants, Lipides Essentiels, Nutrition et maladies OculaiRes) Study. J Nutr Health Aging 14: 854-861. doi:10.1007/s12603-010-0131-9. PubMed: 21125205.
41. Group CS (2003) Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology 22: 316-325
42. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G et al. (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39: 367-374. doi:10.1016/S0039-6257(05)80092-X. PubMed: 7604360.
43. Klein R, Klein BE, Knudtson MD, Wong TY, Cotch MF et al. (2006) Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 113: 373-380. doi:10.1016/j.ophtha.2005.12.013. PubMed: 16513455.
44. Lambert JC, Heath S, Even G, Campion D, Sleegers K et al. (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094-1099. doi:10.1038/ng.439. PubMed: 19734903.
45. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34: 816-834. doi:10.1002/gepi.20533. PubMed: 21058334.
46. Li Y, Willer C, Sanna S, Abecasis G (2009) Genotype imputation. Annu Rev Genomics Hum Genet 10: 387-406. doi:10.1146/annurev.genom.9.081307.164242. PubMed: 19715440.
47. 1000 Genomes Project Consortium, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME, McVean GA (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073. doi:10.1038/nature09534. PubMed: 20981092.
48. Hartmann D, Thürmann PA, Spitzer V, Schalch W, Manner B et al. (2004) Plasma kinetics of zeaxanthin and 3′-dehydro-lutein after multiple oral doses of synthetic zeaxanthin. Am J Clin Nutr 79: 410-417. PubMed: 14985215.
49. Zeger SL, Liang KY, Albert PS (1988) Models for longitudinal data: a generalized estimating equation approach. Biometrics 44: 1049-1060. doi:10.2307/2531734. PubMed: 3233245.
50. Delcourt C, Delyfer MN, Rougier MB, Amouyel P, Colin J et al. (2011) Associations of complement factor H and smoking with early age-related macular degeneration: the ALIENOR study. Invest Ophthalmol Vis Sci 52: 5955-5962. doi:10.1167/iovs.10-6235. PubMed: 21642625.
51. Delcourt C, Delyfer MN, Rougier MB, Lambert JC, Amouyel P et al. (2012) ARMS2 A69S Polymorphism and the Risk for Age-Related Maculopathy: The ALIENOR Study. Arch Ophthalmol 130: 1077-1078. doi:10.1001/archophthalmol.2012.420. PubMed: 22893087.
52. Tyssandier V, Choubert G, Grolier P, Borel P (2002) Carotenoids, mostly the xanthophylls, exchange between plasma lipoproteins. Int J Vitam Nutr Res 72: 300-308. doi:10.1024/0300-9831.72.5.300. PubMed: 12463105.
53. Meyers KJ, Johnson EJ, Bernstein PS, Iyengar SK, Engelman CD et al. (2013) Genetic determinants of macular pigments in women of the carotenoids in age-related eye disease study. Invest Ophthalmol Vis Sci 54: 2333-2345. doi:10.1167/iovs.12-10867. PubMed: 23404124.
54. (2013) Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration. The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial. JAMA: 1-11
55. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M et al. (1995) The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102: 205-210. doi:10.1016/S0161-6420(95)31034-2. PubMed: 7862408.